299 related articles for article (PubMed ID: 22561450)
21. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways.
Sampaio WO; Souza dos Santos RA; Faria-Silva R; da Mata Machado LT; Schiffrin EL; Touyz RM
Hypertension; 2007 Jan; 49(1):185-92. PubMed ID: 17116756
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of ANP by angiotensin-(1-9) via the angiotensin type 2 receptor.
Cha SA; Park BM; Gao S; Kim SH
Life Sci; 2013 Dec; 93(24):934-40. PubMed ID: 24177599
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin-(1-5), an active mediator of renin-angiotensin system, stimulates ANP secretion via Mas receptor.
Yu L; Yuan K; Phuong HT; Park BM; Kim SH
Peptides; 2016 Dec; 86():33-41. PubMed ID: 27660028
[TBL] [Abstract][Full Text] [Related]
24. Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor.
Akhtar S; Chandrasekhar B; Attur S; Dhaunsi GS; Yousif MH; Benter IF
PLoS One; 2015; 10(11):e0141657. PubMed ID: 26536590
[TBL] [Abstract][Full Text] [Related]
25. Ang-(1-7) promotes the migration and invasion of human renal cell carcinoma cells via Mas-mediated AKT signaling pathway.
Zheng S; Yang Y; Song R; Yang X; Liu H; Ma Q; Yang L; Meng R; Tao T; Wang S; He J
Biochem Biophys Res Commun; 2015 May; 460(2):333-40. PubMed ID: 25783053
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin (1-7) prevents angiotensin II-induced nociceptive behaviour via inhibition of p38 MAPK phosphorylation mediated through spinal Mas receptors in mice.
Nemoto W; Ogata Y; Nakagawasai O; Yaoita F; Tadano T; Tan-No K
Eur J Pain; 2014 Nov; 18(10):1471-9. PubMed ID: 24733750
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin-(1-7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger.
Shah A; Gul R; Yuan K; Gao S; Oh YB; Kim UH; Kim SH
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1365-74. PubMed ID: 20190099
[TBL] [Abstract][Full Text] [Related]
28. Heat shock prevents insulin resistance-induced vascular complications by augmenting angiotensin-(1-7) signaling.
Karpe PA; Tikoo K
Diabetes; 2014 Mar; 63(3):1124-39. PubMed ID: 24270982
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver.
Herath CB; Mak K; Burrell LM; Angus PW
Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G99-108. PubMed ID: 23086915
[TBL] [Abstract][Full Text] [Related]
30. Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice.
Tesanovic S; Vinh A; Gaspari TA; Casley D; Widdop RE
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1606-13. PubMed ID: 20448208
[TBL] [Abstract][Full Text] [Related]
31. Burn injury impairs insulin-stimulated Akt/PKB activation in skeletal muscle.
Sugita H; Kaneki M; Sugita M; Yasukawa T; Yasuhara S; Martyn JA
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E585-91. PubMed ID: 15536206
[TBL] [Abstract][Full Text] [Related]
32. Captopril intake decreases body weight gain via angiotensin-(1-7).
Oh YB; Kim JH; Park BM; Park BH; Kim SH
Peptides; 2012 Sep; 37(1):79-85. PubMed ID: 22743141
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of ACE2-ANG-(1-7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport.
Wong TP; Ho KY; Ng EK; Debnam ES; Leung PS
Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E669-81. PubMed ID: 22811473
[TBL] [Abstract][Full Text] [Related]
34. Mas receptor mediates cardioprotection of angiotensin-(1-7) against Angiotensin II-induced cardiomyocyte autophagy and cardiac remodelling through inhibition of oxidative stress.
Lin L; Liu X; Xu J; Weng L; Ren J; Ge J; Zou Y
J Cell Mol Med; 2016 Jan; 20(1):48-57. PubMed ID: 26515045
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin-(1-7) has a dual role on growth-promoting signalling pathways in rat heart in vivo by stimulating STAT3 and STAT5a/b phosphorylation and inhibiting angiotensin II-stimulated ERK1/2 and Rho kinase activity.
Giani JF; Gironacci MM; Muñoz MC; Turyn D; Dominici FP
Exp Physiol; 2008 May; 93(5):570-8. PubMed ID: 18448663
[TBL] [Abstract][Full Text] [Related]
36. Activation of angiotensin-(1-7)/Mas axis in the brain lowers blood pressure and attenuates cardiac remodeling in hypertensive transgenic (mRen2)27 rats.
Kangussu LM; Guimaraes PS; Nadu AP; Melo MB; Santos RA; Campagnole-Santos MJ
Neuropharmacology; 2015 Oct; 97():58-66. PubMed ID: 25983274
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs.
Tassone EJ; Sciacqua A; Andreozzi F; Presta I; Perticone M; Carnevale D; Casaburo M; Hribal ML; Sesti G; Perticone F
Cardiovasc Res; 2013 Jul; 99(1):129-36. PubMed ID: 23524303
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.
Lubel JS; Herath CB; Tchongue J; Grace J; Jia Z; Spencer K; Casley D; Crowley P; Sievert W; Burrell LM; Angus PW
Clin Sci (Lond); 2009 Sep; 117(11):375-86. PubMed ID: 19371232
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanisms involved in the angiotensin-(1-7)/Mas signaling pathway in cardiomyocytes.
Dias-Peixoto MF; Santos RA; Gomes ER; Alves MN; Almeida PW; Greco L; Rosa M; Fauler B; Bader M; Alenina N; Guatimosim S
Hypertension; 2008 Sep; 52(3):542-8. PubMed ID: 18695148
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model.
Marcus Y; Shefer G; Sasson K; Kohen F; Limor R; Pappo O; Nevo N; Biton I; Bach M; Berkutzki T; Fridkin M; Benayahu D; Shechter Y; Stern N
Diabetes; 2013 Apr; 62(4):1121-30. PubMed ID: 23250359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
